iqvia glp-1 prescriptions q3 2024 semaglutide tirzepatide Global Medicines Outlook 2024-2028 | PDF | Economic Growth Lilly weight-loss drug Zepbound new

Evidence from several major clinical trials has shown that GLP-1 RAs can reduce cardiovascular events and slow CKD progression by reducing albuminuria

By delaying stomach emptying and signaling the brain to feel fuller sooner, semaglutide naturally decreases food intake and keeps appetite in check over the day

While DHA has been implicated in isolated cases of ACD, most allergic reactions are likely attributable to other components in product formulations, particularly fragrances, preservatives, and emulsifiers

These gastrointestinal issues, including vomiting and abdominal distention, were among the most frequently reported in Phase I trials